001060
vs
K
KOSPI 200
001060
Over the past 12 months, JW Pharmaceutical Corp has underperformed KOSPI 200, delivering a return of +45% compared to the KOSPI 200's +125% growth.
Stocks Performance
001060 vs KOSPI 200
Performance Gap
001060 vs KOSPI 200
Performance By Year
001060 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JW Pharmaceutical Corp
Glance View
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The firm mainly produces and sells drugs including supplying protein amino acids in blood, blood and fluid substitutes, hyperlipidemia agents, electrolyte additives, angina pectoris agents, rheumatoid arthritis drugs, perfusion fluid, prostatic hypertrophy drugs, hepatic coma drugs, and iron injections, among others. The firm also researches and develops anticancer drugs.
